Search Results - "Neoplastic Cells, Circulating pathology"

Konzept der 'liquid biopsy' in der Versorgung maligner Augentumoren

Authors: Coupland, Sarah E. Sonntag, Svenja R. Heimann, Heinrich et al.

Source: Die Ophthalmologie. 121:946-953

Subject Terms: Tumorbiologie, Circulating Tumor DNA/genetics [MeSH], Early detection of cancer, Leitthema, Prognoseinstrument, Eye Neoplasms/genetics [MeSH], Circulating Tumor DNA/analysis [MeSH], Zirkulierende Tumor-DNA, Tumor biology, Neoplastic Cells, Circulating/pathology [MeSH], Circulating Tumor DNA/blood [MeSH], Prognostic instrument, Humans [MeSH], Eye Neoplasms/diagnosis [MeSH], Oncology, Neoplastic Cells, Circulating/metabolism [MeSH], Eye Neoplasms/therapy [MeSH], Eye Neoplasms/pathology [MeSH], Liquid Biopsy/methods [MeSH], Krebsfrüherkennung, Circulating tumor DNA, Onkologie, Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Eye Neoplasms/blood [MeSH]

Access URL: https://repository.publisso.de/resource/frl:6517534

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer

Authors: Eva Welsch Lilli Bonstingl Barbara Holzer et al.

Source: Clin Exp Metastasis

Subject Terms: Male, Glutamate Carboxypeptidase II, Aged, 80 and over, Neoplastic Cells, Circulating/pathology [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Parsortix, Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], Liquid biopsy, Neoplasm Metastasis [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Antigens, Surface [MeSH], Glutamate Carboxypeptidase II/blood [MeSH], Research Paper, In Situ Hybridization [MeSH], Male [MeSH], Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], qPCR, Gene expression, Circulating tumor cells, Prostate cancer, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Neoplastic Cells, Circulating, Prognosis, Antigens, Surface, Biomarkers, Tumor, Humans, Neoplasm Metastasis, In Situ Hybridization, Aged, Follow-Up Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/39305397
https://repository.publisso.de/resource/frl:6518781

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands

Authors: Erika Tissino Annalisa Gaglio Antonella Nicolò et al.

Contributors: Erika Tissino Annalisa Gaglio Antonella Nicolò et al.

Source: Leukemia

Subject Terms: Real-time analysis: receptor stereotypy, CD49d, survival, activation, expression, CLL, proliferation, Ibrutinib, CD38, Receptors, Antigen, B-Cell, Vascular Cell Adhesion Molecule-1, Integrin alpha4beta1, Ligands, Article, Piperidines, Cell Adhesion, Humans, 96, Adenine/pharmacology [MeSH], Vascular Cell Adhesion Molecule-1/metabolism [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/metabolism [MeSH], Pyrazoles/therapeutic use [MeSH], 13, 631/67/1990/283/1895, Leukemia, Lymphocytic, Chronic, B-Cell/pathology [MeSH], Ligands [MeSH], 38/109, Receptors, Antigen, B-Cell/metabolism [MeSH], 13/31, Pyrimidines/pharmacology [MeSH], Adenine/analogs, Neoplastic Cells, Circulating/pathology [MeSH], 82/80, Cell Adhesion [MeSH], Humans [MeSH], Pyrazoles/pharmacology [MeSH], 13/106, Neoplastic Cells, Circulating/metabolism [MeSH], Integrin alpha4beta1/metabolism [MeSH], Signal Transduction [MeSH], 631/80/86, 14, article, Piperidines/pharmacology [MeSH], Adenine, Settore MED/15, Neoplastic Cells, Circulating, Leukemia, Lymphocytic, Chronic, B-Cell, Pyrimidines, Pyrazoles, Signal Transduction

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39143370
https://hdl.handle.net/11368/3085358
https://www.nature.com/articles/s41375-024-02376-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11436378/
https://hdl.handle.net/20.500.11770/371659
https://doi.org/10.1038/s41375-024-02376-7
https://www.nature.com/articles/s41375-024-02376-7
https://hdl.handle.net/11368/3085358
https://doi.org/10.1038/s41375-024-02376-7
https://repository.publisso.de/resource/frl:6509183
https://hdl.handle.net/20.500.11769/654730
https://doi.org/10.1038/s41375-024-02376-7

Clinical applications of circulating tumor cells in patients with solid tumors

Authors: Smit, Daniel J. Schneegans, Svenja Pantel, Klaus

Source: Clin Exp Metastasis

Subject Terms: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Neoplastic Cells, Circulating/pathology [MeSH], Precision medicine, Clinical application, Neoplasms/pathology [MeSH], Biomarkers, Tumor/blood [MeSH], Humans [MeSH], Liquid biopsy, Review, Neoplasms/diagnosis [MeSH], Circulating tumor cells, Neoplasms/blood [MeSH], Liquid Biopsy/methods [MeSH], Neoplasms, Liquid Biopsy, Biomarkers, Tumor, Humans, Neoplastic Cells, Circulating, 3. Good health

Access URL: https://pubmed.ncbi.nlm.nih.gov/38281256
https://repository.publisso.de/resource/frl:6500487

Determination of the Androgen Receptor Status of Disseminated Tumor Cells in Primary Breast Cancer Patients

Authors: Natalia Krawczyk Bernadette Jaeger Piperek-Jäger Martina et al.

Source: Arch Gynecol Obstet

Subject Terms: Female [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Receptors, Androgen [MeSH], Predictive marker, Humans [MeSH], Prognosis [MeSH], Targeted therapy, Minimal residual disease, Breast Neoplasms/pathology [MeSH], Gynecologic Oncology, Receptors, Androgen, Humans, Female, Breast Neoplasms, Neoplastic Cells, Circulating, Prognosis, 3. Good health

Access URL: https://pubmed.ncbi.nlm.nih.gov/37902839
https://repository.publisso.de/resource/frl:6491794

Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells to improve personalized treatment

Authors: Rivandi, Mahdi Franken, André Yang, Liwen et al.

Source: J Transl Med
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)

Subject Terms: Female [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Cell Line, Tumor [MeSH], Humans [MeSH], Circulating tumor cell, Breast cancer, Breast Neoplasms/blood [MeSH], Breast Neoplasms/metabolism [MeSH], Neoplastic Cells, Circulating/metabolism [MeSH], Personalized medicine, Proto-Oncogene Proteins c-akt/metabolism [MeSH], Research, Single-Cell Analysis [MeSH], Signal Transduction [MeSH], Protein analysis, Precision Medicine [MeSH], Breast Neoplasms/pathology [MeSH], Single cell proteomics, Protein Array Analysis [MeSH], Network Medicines, Protein Array Analysis, Breast Neoplasms, Neoplastic Cells, Circulating, Cell Line, Tumor, Medicine, Humans, Female, Precision Medicine, Single-Cell Analysis, Proto-Oncogene Proteins c-akt, Signal Transduction

Access URL: https://pubmed.ncbi.nlm.nih.gov/39304879
https://doaj.org/article/5e6118968ad849adb83b99912c0b09d9
https://repository.publisso.de/resource/frl:6494214

Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients

Authors: Løppke, Caroline Jørgensen, Amalie M Sand, Nicolai T et al.

Source: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Løppke, C, Jørgensen, A M, Sand, N T, Klitgaard, R B, Daugaard, G & Agerbæk, M Ø 2024, ' Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients ', Scientific Reports, vol. 14, no. 1, 17501 . https://doi.org/10.1038/s41598-024-68336-4

Subject Terms: Male, 0301 basic medicine, Science, Microfluidics, Microfluidic Analytical Techniques/instrumentation, Prostatic Neoplasms/pathology, Cell Separation, Neoplastic Cells, Article, Cell Line, Workflow, 03 medical and health sciences, 0302 clinical medicine, Cell Line, Tumor, Biomarkers, Tumor, Humans, Microfluidics/methods, Neoplasm Metastasis, Neoplastic Cells, Circulating/pathology, Tumor, Staining and Labeling, Single-Cell Analysis/methods, Prostatic Neoplasms, Microfluidic Analytical Techniques, Neoplastic Cells, Circulating, 3. Good health, Tumor/genetics, Medicine, Biomarkers, Tumor/genetics, Single-Cell Analysis, Cell Separation/methods, Circulating/pathology, Biomarkers, Staining and Labeling/methods

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39080445
https://doaj.org/article/95bb74154b1841c38598cb82da671ec2
https://curis.ku.dk/ws/files/412339043/Combined_microfuidic.pdf

Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells

Authors: Rieckmann, Lisa-Marie Spohn, Michael Ruff, Lisa et al.

Source: Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Molecular Cancer

Subject Terms: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, Non-small cell lung cancer, Correspondence, Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Cell Line, Tumor [MeSH], Carcinoma, Non-Small-Cell Lung/genetics [MeSH], Humans [MeSH], Lung Neoplasms/genetics [MeSH], Lung Neoplasms/diagnosis [MeSH], Leukapheresis [MeSH], Neoplastic Cells, Circulating/metabolism [MeSH], Epithelial-Mesenchymal Transition/genetics [MeSH], Carcinoma, Non-Small-Cell Lung/diagnosis [MeSH], Intratumor heterogeneity, Single cell RNA sequencing, Single-Cell Analysis/methods [MeSH], Lung Neoplasms/pathology [MeSH], Transcriptome [MeSH], Phenotype [MeSH], Circulating tumor cells, Biomarkers, Tumor [MeSH], Gene Expression Profiling [MeSH], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, 3. Good health

Access URL: https://doaj.org/article/2c341ef7571b4502937a3beb26a74b4b
https://repository.publisso.de/resource/frl:6503899

Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest

Authors: Liu, Haiyan E. Vuppalapaty, Meghah Hoerner, Christian R. et al.

Source: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)

Subject Terms: Male, 0301 basic medicine, Castration resistance, Exosomes, 03 medical and health sciences, 0302 clinical medicine, PSMA, Androgen Receptor Antagonists, Biomarkers, Tumor, Humans, Protein Isoforms, RNA, Messenger, RC254-282, Prostate cancer, Research, Prostate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Therapeutic resistance, Prostate-Specific Antigen, Neoplastic Cells, Circulating, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Androgen receptor inhibitors, AR-V7, Androgen Receptor Antagonists/therapeutic use [MeSH], Prostate-Specific Antigen [MeSH], Receptors, Androgen/metabolism [MeSH], RNA, Messenger/genetics [MeSH], Receptors, Androgen/genetics [MeSH], Male [MeSH], Androgen Receptor Antagonists/pharmacology [MeSH], Prostate/pathology [MeSH], Cell-Free Nucleic Acids/metabolism [MeSH], Circulating tumor cells, Cell-Free Nucleic Acids/genetics [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Humans [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Exosomes/metabolism [MeSH], Protein Isoforms/genetics [MeSH], Cell-free RNA, Biomarkers, Tumor/genetics [MeSH], Exosomes/genetics [MeSH], Cell-Free Nucleic Acids

Access URL: https://pubmed.ncbi.nlm.nih.gov/38627648
https://doaj.org/article/f147876cb7db462d84fa5bc412a8c4d4
https://repository.publisso.de/resource/frl:6520065

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status

Authors: Theresa Vilsmaier Helene Hildegard Heidegger Lennard Schröder et al.

Source: Arch Gynecol Obstet

Subject Terms: Adult, Interleukin-15, 2. Zero hunger, Aged [MeSH], Interleukin-15/blood [MeSH], Breast cancer, Progression-Free Survival [MeSH], Lymphatic Metastasis [MeSH], SUCCESS study, Chemokines/blood [MeSH], Circulating tumor cells, Eotaxin, Breast Neoplasms/pathology [MeSH], Female [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Carboplatin [MeSH], Cyclophosphamide [MeSH], Adult [MeSH], Humans [MeSH], Breast Neoplasms/blood [MeSH], Survival Analysis [MeSH], Thiotepa [MeSH], Interleukin 15, Middle Aged [MeSH], Biomarkers, Tumor/blood [MeSH], Disease-Free Survival [MeSH], Prognosis [MeSH], Antineoplastic Combined Chemotherapy Protocols [MeSH], Gynecologic Oncology, Breast Neoplasms, Middle Aged, Neoplastic Cells, Circulating, Prognosis, Survival Analysis, Disease-Free Survival, Progression-Free Survival, Carboplatin, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Lymphatic Metastasis, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Female, Chemokines, Cyclophosphamide, Thiotepa, Aged

Access URL: https://link.springer.com/content/pdf/10.1007/s00404-020-05793-y.pdf
https://pubmed.ncbi.nlm.nih.gov/32929618
https://link.springer.com/article/10.1007/s00404-020-05793-y
https://pubmed.ncbi.nlm.nih.gov/32929618/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854415
https://epub.ub.uni-muenchen.de/75775/
https://link.springer.com/content/pdf/10.1007/s00404-020-05793-y.pdf
https://repository.publisso.de/resource/frl:6466700
https://epub.ub.uni-muenchen.de/75775/

HER2-targeted therapy influences CTC status in metastatic breast cancer

Authors: Thomas M. Deutsch Sabine Riethdorf Carlo Fremd et al.

Source: Breast Cancer Res Treat

Subject Terms: Adult, Receptor, ErbB-2, Breast Neoplasms, Lapatinib, Middle Aged, Trastuzumab, Antibodies, Monoclonal, Humanized, Neoplastic Cells, Circulating, Prognosis, Clinical Trial, Female [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Disease Progression [MeSH], Follow-Up Studies [MeSH], Circulating tumor cells (CTC), Adult [MeSH], Receptor, ErbB-2/metabolism [MeSH], Humans [MeSH], Trastuzumab/administration, Breast Neoplasms/drug therapy [MeSH], Antibodies, Monoclonal, Humanized/administration, Breast Neoplasms/blood [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], HER2-targeted therapy, Lapatinib/administration, Human epidermal growth factor receptor 2 (HER2), Prognosis [MeSH], Receptor, ErbB-2/antagonists, Metastatic breast cancer (MBC), Breast Neoplasms/pathology [MeSH], 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Disease Progression, Humans, Female, Follow-Up Studies, Retrospective Studies

Access URL: https://link.springer.com/content/pdf/10.1007/s10549-020-05687-2.pdf
https://pubmed.ncbi.nlm.nih.gov/32436146
https://rd.springer.com/article/10.1007/s10549-020-05687-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274999
https://link.springer.com/content/pdf/10.1007/s10549-020-05687-2.pdf
https://pubmed.ncbi.nlm.nih.gov/32436146/
https://www.scilit.net/article/d784f438aff339a883413562a92a9b6b
https://link.springer.com/article/10.1007/s10549-020-05687-2
https://repository.publisso.de/resource/frl:6470712

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

Authors: Jiajia Tang Quan Zheng Qi Wang et al.

Source: Cell Rep Med
Cell Reports Medicine, Vol 5, Iss 9, Pp 101692-(2024)
Tang, J, Zheng, Q, Wang, Q, Zhao, Y, Ananthanarayanan, P, Reina, C, Šabanović, B, Jiang, K, Yang, M-H, Meny, C C, Wang, H, Agerbaek, M Ø, Clausen, T M, Gustavsson, T, Wen, C, Borghi, F, Mellano, A, Fenocchio, E, Gregorc, V, Sapino, A, Theander, T G, Fu, D, Aicher, A, Salanti, A, Shen, B & Heeschen, C 2024, ' CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches ', Cell Reports Medicine, vol. 5, no. 9, 101692 . https://doi.org/10.1016/j.xcrm.2024.101692

Subject Terms: Male, Medicine (General), Receptors, CXCR4, Pancreatic Neoplasms/pathology, Receptors, CXCR4/metabolism, pancreatic cancer, CXCR4/metabolism, compound screening, Carcinoma, Pancreatic Ductal/pathology, Neoplastic Cells, Article, Cell Line, Mice, R5-920, Neoplastic Stem Cells/metabolism, Cell Line, Tumor, Receptors, Tumor/metabolism, Biomarkers, Tumor, Humans, Animals, Precision Medicine, Neoplastic Cells, Circulating/pathology, Aged, CXCR4, Tumor, liquid biopsy, Carcinoma, circulating cancer stem cells, Precision Medicine/methods, Middle Aged, Pancreatic Ductal/pathology, Neoplastic Cells, Circulating, Stearoyl-CoA Desaturase/metabolism, Pancreatic Neoplasms, Biomarkers, Tumor/metabolism, Neoplastic Stem Cells, Female, metabolism, Circulating/pathology, Biomarkers, Stearoyl-CoA Desaturase, Carcinoma, Pancreatic Ductal

File Description: text/html

Access URL: https://pubmed.ncbi.nlm.nih.gov/39163864
https://doaj.org/article/ed0af2f0abc443e89c00860a71176afe
https://curis.ku.dk/ws/files/412332155/CTC_derived_pancreatic.htm

Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications

Authors: Gniadecki, R. Guenova, E. Querfeld, C. et al.

Source: The British journal of dermatology, vol. 192, no. 3, pp. 381-389

Subject Terms: Sezary Syndrome/pathology, Sezary Syndrome/genetics, Humans, Mycosis Fungoides/pathology, Skin Neoplasms/pathology, Skin Neoplasms/genetics, Neoplasm Seeding, Neoplastic Cells, Circulating/pathology, Disease Progression, Cell Transformation, Neoplastic/pathology, Cell Transformation, Neoplastic/genetics

File Description: application/pdf

Access URL: https://serval.unil.ch/resource/serval:BIB_D9AD55C8E0FE.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_D9AD55C8E0FE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D9AD55C8E0FE9

Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

Authors: Charles Swanton Maise Al Bakir Francesca Chemi et al.

Source: TRACERx Consortium 2019, 'Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse', Nature Medicine, vol. 25, no. 10, pp. 1534-1539. https://doi.org/10.1038/s41591-019-0593-1
Chemi, F, Rothwell, D G, McGranahan, N, Gulati, S, Abbosh, C, Pearce, S P, Zhou, C, Wilson, G A, Jamal-Hanjani, M, Birkbak, N, Pierce, J, Kim, C S, Ferdous, S, Burt, D J, Slane-Tan, D, Gomes, F, Moore, D, Shah, R, Al Bakir, M, Hiley, C, Veeriah, S, Summers, Y, Crosbie, P, Ward, S, Mesquita, B, Dynowski, M, Biswas, D, Tugwood, J, Blackhall, F, Miller, C, Hackshaw, A, Brady, G, Swanton, C, Dive, C & TRACERx Consortium 2019, 'Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse', Nature Medicine, vol. 25, no. 10, pp. 1534-1539. https://doi.org/10.1038/s41591-019-0593-1

Subject Terms: Adult, Male, 0301 basic medicine, Carcinoma, Non-Small-Cell Lung/diagnosis, Neoplastic Cells, Local/diagnosis, Neoplasm Recurrence, Local/diagnosis, 03 medical and health sciences, Carcinoma, Non-Small-Cell Lung, 80 and over, Biomarkers, Tumor, Humans, Neoplasm Metastasis, Neoplastic Cells, Circulating/pathology, Aged, Neoplasm Staging, Aged, 80 and over, 0303 health sciences, Genome, Human/genetics, Non-Small-Cell Lung/diagnosis, Genome, Human, Carcinoma, Neoplastic/genetics, Middle Aged, Neoplastic Cells, Circulating, 3. Good health, Gene Expression Regulation, Neoplastic, Gene Expression Regulation, Neoplastic/genetics, Neoplasm Recurrence, Gene Expression Regulation, Pulmonary Veins, Genome, Human/genetics, Tumor/genetics, Female, Pulmonary Veins/pathology, Biomarkers, Tumor/genetics, Neoplasm Recurrence, Local, Biomarkers, Circulating/pathology

Access URL: https://europepmc.org/articles/pmc6986897?pdf=render
https://pubmed.ncbi.nlm.nih.gov/31591595
https://research.manchester.ac.uk/en/publications/cce189d9-1bac-4d24-8889-3c9a577a7da6
https://doi.org/10.1038/s41591-019-0593-1
https://christie.openrepository.com/handle/10541/622254
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986897
https://pubmed.ncbi.nlm.nih.gov/31591595/
https://www.ncbi.nlm.nih.gov/pubmed/31591595
https://discovery.ucl.ac.uk/id/eprint/10083787/
http://www-nature-com-443.webvpn.bjmu.tsg211.com/articles/s41591-019-0593-1
https://research.manchester.ac.uk/en/publications/cce189d9-1bac-4d24-8889-3c9a577a7da6
https://discovery.ucl.ac.uk/id/eprint/10083787/
https://doi.org/10.1038/s41591-019-0593-1
https://pure.au.dk/portal/en/publications/704a2f6c-9597-4354-8bc3-26e9636632a2
http://www.scopus.com/inward/record.url?scp=85074198351&partnerID=8YFLogxK
https://doi.org/10.1038/s41591-019-0593-1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986897/pdf/EMS85582.pdf

Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer

Authors: Corinna Keup Vinay Suryaprakash Siegfried Hauch et al.

Source: Genome Med
Genome Medicine, Vol 13, Iss 1, Pp 1-14 (2021)

Subject Terms: Clinical Decision-Making [MeSH], Liquid biopsy, Breast Neoplasms/epidemiology [MeSH], Disease Management [MeSH], Metastatic breast cancer patients, Sensitivity and Specificity [MeSH], Multi-modal, Circulating Tumor DNA [MeSH], Breast Neoplasms/diagnosis [MeSH], Sequence Analysis, DNA [MeSH], Biomarkers, Tumor [MeSH], Breast Neoplasms/etiology [MeSH], Female [MeSH], Neoplastic Cells, Circulating/pathology [MeSH], Humans [MeSH], Multi-parametric, Breast Neoplasms/metabolism [MeSH], Multi-layer, Disease Susceptibility [MeSH], Neoplastic Cells, Circulating/metabolism [MeSH], Liquid Biopsy/methods [MeSH], Multi-analyte, Liquid Biopsy/statistics, Research, Prognosis [MeSH], Liquid Biopsy/standards [MeSH], Computational Biology/methods [MeSH], High-Throughput Nucleotide Sequencing [MeSH], Real-Time Polymerase Chain Reaction [MeSH], Multi-parametric -- Multi-layer -- Multi-modal -- Multi-analyte -- Liquid biopsy -- Metastatic breast cancer patients, Clinical Decision-Making, Medizin, Breast Neoplasms, QH426-470, Real-Time Polymerase Chain Reaction, Sensitivity and Specificity, Circulating Tumor DNA, 03 medical and health sciences, 0302 clinical medicine, Genetics, Biomarkers, Tumor, Humans, ddc:610, 2. Zero hunger, Liquid Biopsy, Computational Biology, Disease Management, High-Throughput Nucleotide Sequencing, Sequence Analysis, DNA, Neoplastic Cells, Circulating, Prognosis, Medizinische Fakultät » Universitätsklinikum Essen » Klinik für Frauenheilkunde und Geburtshilfe, 3. Good health, Medicine, Female, Disease Susceptibility, ScholarlyArticle

Access URL: https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-021-00902-1
https://pubmed.ncbi.nlm.nih.gov/34001236
https://doaj.org/article/39103299acfb493b841699ff8cdd9777
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130163
https://pubmed.ncbi.nlm.nih.gov/34001236/
https://link.springer.com/content/pdf/10.1186/s13073-021-00902-1.pdf
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-021-00902-1
https://europepmc.org/article/MED/34001236
https://link.springer.com/article/10.1186/s13073-021-00902-1
https://repository.publisso.de/resource/frl:6465938
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00081912/Genome_Med_2021_13_85.pdf
https://www.ncbi.nlm.nih.gov/pubmed/34001236
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85106002951
https://doi.org/10.1186/s13073-021-00902-1
https://duepublico2.uni-due.de/receive/duepublico_mods_00081949

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study: A prospective multicentric study

Authors: Charles Ferté Jean-Philippe Spano Paul Hofman et al.

Contributors: Charles Ferté Jean-Philippe Spano Paul Hofman et al.

Source: European Journal of Cancer. 83:185-193

Subject Terms: Adult, Male, 0301 basic medicine, Cell Count, Sensitivity and Specificity, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Neoplasms, Biomarkers, Tumor, Humans, Prospective Studies, cell count, Response Evaluation Criteria in Solid Tumors, Neoplastic Cells, Circulating/pathology, Aged, Clinical Trials, Phase I as Topic, Middle Aged, Neoplastic Cells, Circulating, Survival Analysis, 3. Good health, Biomarkers, Tumor/blood, Neoplasms/blood, young adult, Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/28743036
https://www.sciencedirect.com/science/article/pii/S0959804917309711
https://www.ncbi.nlm.nih.gov/pubmed/28743036
https://biblio.vub.ac.be/vubir/(731cbf50-b2dd-4f34-b5c6-b28e956a4cc8).html

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis

Authors: Giovanni Nitti Charles C. Guo Neema Navai et al.

Source: Oncotarget
Oncotarget, vol. 8, no. 21, pp. 34205-34222
Roth, Beat; Jayaratna, Isuru; Sundi, Debasish; Cheng, Tiewei; Melquist, Jonathan; Choi, Woonyoung; Porten, Sima; Nitti, Giovanni; Navai, Neema; Wszolek, Matthew; Guo, Charles; Czerniak, Bogdan; McConkey, David; Dinney, Colin (2017). Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. OncoTarget, 8(21), pp. 34205-34222. Impact Journals LLC 10.18632/oncotarget.11009 <http://dx.doi.org/10.18632/oncotarget.11009>

Subject Terms: Epithelial-Mesenchymal Transition, 610 Medicine & health, circulating tumor cells, 12. Responsible consumption, 03 medical and health sciences, 0302 clinical medicine, Transforming Growth Factor beta, Cell Line, Tumor, metastasis, Animals, Humans, Neoplasm Metastasis, Whole Genome Sequencing, SNAIL, Gene Expression Profiling, Neoplastic Cells, Circulating, Disease Models, Animal, Disease Progression, Gene Expression Regulation, Neoplastic, Neoplastic Cells, Circulating/metabolism, Neoplastic Cells, Circulating/pathology, Signal Transduction/drug effects, Snail Family Transcription Factors/genetics, Snail Family Transcription Factors/metabolism, Transforming Growth Factor beta/genetics, Transforming Growth Factor beta/metabolism, Urinary Bladder Neoplasms/genetics, Urinary Bladder Neoplasms/metabolism, Urinary Bladder Neoplasms/pathology, bladder cancer, orthotopic xenografts, 3. Good health, Urinary Bladder Neoplasms, 13. Climate action, Snail Family Transcription Factors, Research Paper, Signal Transduction

File Description: application/pdf

Access URL: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=11009&path%5B%5D=34860
https://pubmed.ncbi.nlm.nih.gov/27494900
https://europepmc.org/articles/PMC5470961
https://jhu.pure.elsevier.com/en/publications/employing-an-orthotopic-model-to-study-the-role-of-epithelialmese
https://www.oncotarget.com/fulltext/11009
https://boris.unibe.ch/108826/
https://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=11009
https://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=11009
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_62307F91C3C70
https://serval.unil.ch/notice/serval:BIB_62307F91C3C7
https://serval.unil.ch/resource/serval:BIB_62307F91C3C7.P001/REF.pdf
https://boris.unibe.ch/108826/

Anterior Approach Versus Conventional Approach Right Hepatic Resection for Large Hepatocellular Carcinoma: A Prospective Randomized Controlled Study

Authors: Cheung, ST Fan, ST Wong, J et al.

Source: Annals of Surgery. 244:194-203

Subject Terms: Male, Carcinoma, Hepatocellular, Blood Loss, Surgical, Liver Circulation - physiology, Neoplastic Cells, Disease-Free Survival, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Surgical, Carcinoma, Hepatocellular - pathology - surgery, Cause of Death, Hepatectomy, Humans, Blood Loss, Blood Transfusion, Longitudinal Studies, Prospective Studies, RNA, Messenger, Hepatocellular - pathology - surgery, Neoplasm Staging, Hepatectomy - classification - methods, Liver Neoplasms - pathology - surgery, Circulating - pathology, Carcinoma, Liver Neoplasms, Neoplastic Cells, Circulating - pathology, Length of Stay, Middle Aged, Neoplastic Cells, Circulating, 3. Good health, Survival Rate, Messenger - analysis, Treatment Outcome, RNA, Messenger - analysis, RNA, Female, Serum Albumin - analysis, Follow-Up Studies, Liver Circulation

Access URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1602174
https://pubmed.ncbi.nlm.nih.gov/16858181
https://www.ncbi.nlm.nih.gov/pubmed/16858181
https://insights.ovid.com/crossref?an=00000658-200608000-00005
https://europepmc.org/article/MED/16858181
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16858181/
https://pubmed.ncbi.nlm.nih.gov/16858181/
https://journals.lww.com/00000658-200608000-00005
http://hdl.handle.net/10722/88419
http://hdl.handle.net/10722/104859

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

Authors: Peeters, D J E DJ De Laere, Bram Van den Eynden, Gert et al.

Source: Br J Cancer
The British journal of cancer
British Journal of Cancer, 108 (6

Subject Terms: 0301 basic medicine, Breast Neoplasms, Cell Separation, Neoplastic Cells, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Biomarkers, Tumor, Humans, RSM MKT, Mutation -- genetics, Molecular Diagnostics, Breast Neoplasms -- blood -- genetics -- pathology, Biomarkers, Tumor -- blood -- genetics, Cell Separation -- instrumentation -- methods, Gene Expression Profiling, Circulating -- pathology, Médecine pathologie humaine, Sciences bio-médicales et agricoles, Neoplastic Cells, Circulating, Cancérologie, Mutation, Neoplastic Cells, Circulating -- pathology, Female, Human medicine, EMC MM-03-86-01, Tumor -- blood -- genetics, Biomarkers

File Description: 1 full-text file(s): application/pdf

Access URL: https://www.nature.com/articles/bjc201392.pdf
https://pubmed.ncbi.nlm.nih.gov/23470469
https://pure.eur.nl/en/publications/4e2e0cab-74c0-41db-a97b-dd9a63d39413
https://doi.org/10.1038/bjc.2013.92
https://nature.com/articles/bjc201392
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247862/Details
https://www.ncbi.nlm.nih.gov/pubmed/23470469
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619252/
https://www.nature.com/articles/bjc201392.pdf
https://hdl.handle.net/10067/1084740151162165141
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247862

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

Authors: Martine Piccart Catherine Alix-Panabières Wolfgang Janni et al.

Contributors: Martine Piccart Catherine Alix-Panabières Wolfgang Janni et al.

Source: Cancer Metastasis Rev
Cancer metastasis reviews, 32 (1-2

Subject Terms: Cancer Research, CirCe XXX1, CellSearch®, CirCe 01, Antineoplastic Agents, Breast Neoplasms, CirCe T-DM1, circulating tumor cells, Neoplastic Cells, Non-Thematic Review, Breast Neoplasms -- diagnosis -- drug therapy -- pathology, ETI score, 03 medical and health sciences, Breast cancer, breast cancer, 0302 clinical medicine, TREAT CTC, [SDV.CAN] Life Sciences [q-bio]/Cancer, STIC CTC METABREAST, CirCeXXX1, Humans, STIC CTC, CirCe01, Clinical Trials as Topic, phase III trials, cancer du sein, Circulating -- pathology, Circulating tumor cells, Detect III, Neoplastic Cells, Circulating, CTC, United States, 3. Good health, Cancérologie, Europe, CirCeT-DM1, Treatment Outcome, cellules tumorales circulantes, Oncology, Antineoplastic Agents -- therapeutic use, Neoplastic Cells, Circulating -- pathology, Female

File Description: application/pdf; 1 full-text file(s): application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007%2Fs10555-012-9398-0.pdf
https://pubmed.ncbi.nlm.nih.gov/23129208
https://link.springer.com/content/pdf/10.1007%2Fs10555-012-9398-0.pdf
https://core.ac.uk/display/81729287
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655223
https://www.europepmc.org/articles/PMC3655223/
https://rd.springer.com/article/10.1007/s10555-012-9398-0
https://www.hal.inserm.fr/inserm-00749450
https://inserm.hal.science/inserm-00749450v2/document
https://doi.org/10.1007/s10555-012-9398-0
https://inserm.hal.science/inserm-00749450v2
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144334